Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen
NCT: NCT07575568 · NOT_YET_RECRUITING
광고
NCT IDNCT07575568
상태NOT_YET_RECRUITING
간략 요약
The objective of this first-in-human study is to assess the safety and effectiveness of the Serranator Sonic Intravascular Lithotripsy (IVL) System™ for the treatment of peripheral artery disease.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.